<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38734183</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Design of antiviral AGO2-dependent short hairpin RNAs.</ArticleTitle><Pagination><StartPage>645</StartPage><EndPage>654</EndPage><MedlinePgn>645-654</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2024.05.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(24)00069-5</ELocationID><Abstract><AbstractText>The increasing emergence and re-emergence of RNA virus outbreaks underlines the urgent need to develop effective antivirals. RNA interference (RNAi) is a sequence-specific gene silencing mechanism that is triggered by small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs), which exhibits significant promise for antiviral therapy. AGO2-dependent shRNA (agshRNA) generates a single-stranded guide RNA and presents significant advantages over traditional siRNA and shRNA. In this study, we applied a logistic regression algorithm to a previously published chemically siRNA efficacy dataset and built a machine learning-based model with high predictive power. Using this model, we designed siRNA sequences targeting diverse RNA viruses, including human enterovirus A71 (EV71), Zika virus (ZIKV), dengue virus 2 (DENV2), mouse hepatitis virus (MHV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and transformed them into agshRNAs. We validated the performance of our agshRNA design by evaluating antiviral efficacies of agshRNAs in cells infected with different viruses. Using the agshRNA targeting EV71 as an example, we showed that the anti-EV71 effect of agshRNA was more potent compared with the corresponding siRNA and shRNA. Moreover, the antiviral effect of agshRNA is dependent on AGO2-processed guide RNA, which can load into the RNA-induced silencing complex (RISC). We also confirmed the antiviral effect of agshRNA in vivo. Together, this work develops a novel antiviral strategy that combines machine learning-based algorithm with agshRNA design to custom design antiviral agshRNAs with high efficiency.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bie</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jieling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiyao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yumin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Muhan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Leike</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese Academy of Sciences, Beijing 100049, China; School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China. Electronic address: zhouxi@wh.iov.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese Academy of Sciences, Beijing 100049, China; School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China. Electronic address: yangqiu@wh.iov.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060565">Argonaute Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C466422">AGO2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="Y">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060565" MajorTopicYN="Y">Argonaute Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AgshRNA</Keyword><Keyword MajorTopicYN="N">Antiviral strategy</Keyword><Keyword MajorTopicYN="N">Machine learning model</Keyword></KeywordList><CoiStatement>Conflict of interest Professor Xi Zhou is an editorial board member for Virologica Sinica and were not involved in the editorial review or the decision to publish this article. The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>11</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38734183</ArticleId><ArticleId IdType="pmc">PMC11401469</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2024.05.001</ArticleId><ArticleId IdType="pii">S1995-820X(24)00069-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alsing S., Doktor T.K., Askou A.L., Jensen E.G., Ahmadov U., Kristensen L.S., Andresen B.S., Aagaard L., Corydon T.J. Vegfa-targeting mir-agshRNAs combine efficacy with specificity and safety for retinal gene therapy. Mol. Ther. Nucleic Acids. 2022;28:58–76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8933642</ArticleId><ArticleId IdType="pubmed">35356684</ArticleId></ArticleIdList></Reference><Reference><Citation>Anobile D.P., Poirier E.Z. RNA interference, an emerging component of antiviral immunity in mammals. Biochem. Soc. Trans. 2023;51:137–146.</Citation><ArticleIdList><ArticleId IdType="pubmed">36606711</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. Metazoan micrornas. Cell. 2018;173:20–51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Birmingham A., Anderson E.M., Reynolds A., Ilsley-Tyree D., Leake D., Fedorov Y., Baskerville S., Maksimova E., Robinson K., Karpilow J., Marshall W.S., Khvorova A. 3’ utr seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods. 2006;3:199–204.</Citation><ArticleIdList><ArticleId IdType="pubmed">16489337</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogerd H.P., Whisnant A.W., Kennedy E.M., Flores O., Cullen B.R. Derivation and characterization of dicer- and microRNA-deficient human cells. RNA. 2014;20:923–937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4024645</ArticleId><ArticleId IdType="pubmed">24757167</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillaud M., El Madani M., Massaad-Massade L. Small interfering RNA from the lab discovery to patients’ recovery. J. Control. Release. 2020;321:616–628.</Citation><ArticleIdList><ArticleId IdType="pubmed">32087301</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheloufi S., Dos Santos C.O., Chong M.M., Hannon G.J. A dicer-independent miRNA biogenesis pathway that requires AGO catalysis. Nature. 2010;465:584–589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995450</ArticleId><ArticleId IdType="pubmed">20424607</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.H., Croyle M.A. Emerging targets and novel approaches to ebola virus prophylaxis and treatment. BioDrugs. 2013;27:565–583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833964</ArticleId><ArticleId IdType="pubmed">23813435</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuentes D., Xue H., Taylor D.W., Patnode H., Mishima Y., Cheloufi S., Ma E., Mane S., Hannon G.J., Lawson N.D., Wolfe S.A., Giraldez A.J. A novel miRNA processing pathway independent of dicer requires argonaute2 catalytic activity. Science. 2010;328:1694–1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093307</ArticleId><ArticleId IdType="pubmed">20448148</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson B.L., McCray P.B., Jr. Current prospects for RNA interference-based therapies. Nat. Rev. Genet. 2011;12:329–340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097665</ArticleId><ArticleId IdType="pubmed">21499294</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVincenzo J., Lambkin-Williams R., Wilkinson T., Cehelsky J., Nochur S., Walsh E., Meyers R., Gollob J., Vaishnaw A. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc. Natl. Acad. Sci. U. S. A. 2010;107:8800–8805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2889365</ArticleId><ArticleId IdType="pubmed">20421463</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y., Liu Z., Qiu Y., Kong J., Fu Y., Liu Y., Wang C., Quan J., Wang Q., Xu W., Yin L., Cui J., Xu Y., Curry S., Jiang S., Lu L., Zhou X. Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivo. Immunity. 2021;54:2231–2244.e2236.</Citation><ArticleIdList><ArticleId IdType="pubmed">34555337</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Berkhout B., Herrera-Carrillo E. Boosting agoshRNA activity by optimized 5’-terminal nucleotide selection. RNA Biol. 2019;16:890–898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546398</ArticleId><ArticleId IdType="pubmed">30991896</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebert L.F., Rebhan M.A., Crivelli S.E., Denzler R., Stoffel M., Hall J. Miravirsen (spc3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 2014;42:609–621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3874169</ArticleId><ArticleId IdType="pubmed">24068553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghildiyal M., Zamore P.D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 2009;10:94–108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2724769</ArticleId><ArticleId IdType="pubmed">19148191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gish R.G., Satishchandran C., Young M., Pachuk C. RNA interference and its potential applications to chronic HBV treatment: results of a phase i safety and tolerability study. Antivir. Ther. 2011;16:547–554.</Citation><ArticleIdList><ArticleId IdType="pubmed">21685542</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm D., Wang L., Lee J.S., Schürmann N., Gu S., Börner K., Storm T.A., Kay M.A. Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J. Clin. Invest. 2010;120:3106–3119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929739</ArticleId><ArticleId IdType="pubmed">20697157</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature. 2006;441:537–541.</Citation><ArticleIdList><ArticleId IdType="pubmed">16724069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M., Kim V.N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 2014;15:509–524.</Citation><ArticleIdList><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Carrillo E., Berkhout B. Dicer-independent processing of small RNA duplexes: mechanistic insights and applications. Nucleic Acids Res. 2017;45:10369–10379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5737282</ArticleId><ArticleId IdType="pubmed">28977573</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Carrillo E., Harwig A., Berkhout B. Toward optimization of agoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs. RNA Biol. 2015;12:447–456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615845</ArticleId><ArticleId IdType="pubmed">25747107</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Carrillo E., Harwig A., Berkhout B. Silencing of HIV-1 by agoshRNA molecules. Gene Ther. 2017;24:453–461.</Citation><ArticleIdList><ArticleId IdType="pubmed">28553929</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Carrillo E., Gao Z., Berkhout B. Influence of a 3’ terminal ribozyme on agoshRNA biogenesis and activity. Mol. Ther. Nucleic Acids. 2019;16:452–462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6488825</ArticleId><ArticleId IdType="pubmed">31048184</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Carrillo E., Gao Z.L., Harwig A., Heemskerk M.T., Berkhout B. The influence of the 5΄-terminal nucleotide on agoshRNA activity and biogenesis: importance of the polymerase iii transcription initiation site. Nucleic Acids Res. 2017;45:4036–4050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5397164</ArticleId><ArticleId IdType="pubmed">27928054</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Zhong L., Weng Y., Peng L., Huang Y., Zhao Y., Liang X.J. Therapeutic siRNA: state of the art. Signal Transduct. Target. Ther. 2020;5:101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7305320</ArticleId><ArticleId IdType="pubmed">32561705</ArticleId></ArticleIdList></Reference><Reference><Citation>Huesken D., Lange J., Mickanin C., Weiler J., Asselbergs F., Warner J., Meloon B., Engel S., Rosenberg A., Cohen D., Labow M., Reinhardt M., Natt F., Hall J. Design of a genome-wide siRNA library using an artificial neural network. Nat. Biotechnol. 2005;23:995–1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">16025102</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntzinger E., Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 2011;12:99–110.</Citation><ArticleIdList><ArticleId IdType="pubmed">21245828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichihara M., Murakumo Y., Masuda A., Matsuura T., Asai N., Jijiwa M., Ishida M., Shinmi J., Yatsuya H., Qiao S., Takahashi M., Ohno K. Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities. Nucleic Acids Res. 2007;35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2094068</ArticleId><ArticleId IdType="pubmed">17884914</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 2003;21:635–637.</Citation><ArticleIdList><ArticleId IdType="pubmed">12754523</ArticleId></ArticleIdList></Reference><Reference><Citation>Knott S.R.V., Maceli A., Erard N., Chang K., Marran K., Zhou X., Gordon A., Demerdash O.E., Wagenblast E., Kim S., Fellmann C., Hannon G.J. A computational algorithm to predict shRNA potency. Mol. Cell. 2014;56:796–807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272634</ArticleId><ArticleId IdType="pubmed">25435137</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J., Bie Y., Ji W., Xu J., Lyu B., Xiong X., Qiu Y., Zhou X. Alphavirus infection triggers antiviral RNAi immunity in mammals. Cell Rep. 2023;42</Citation><ArticleIdList><ArticleId IdType="pubmed">37104090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisowiec-Wąchnicka J., Bartyś N., Pasternak A. A systematic study on the influence of thermodynamic asymmetry of 5’-ends of siRNA duplexes in relation to their silencing potency. Sci. Rep. 2019;9:2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6385221</ArticleId><ArticleId IdType="pubmed">30792489</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.P., Schopman N.C., Berkhout B. Dicer-independent processing of short hairpin RNAs. Nucleic Acids Res. 2013;41:3723–3733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3616727</ArticleId><ArticleId IdType="pubmed">23376931</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.P., Karg M., Harwig A., Herrera-Carrillo E., Jongejan A., van Kampen A., Berkhout B. Mechanistic insights on the dicer-independent AGO2-mediated processing of AgoshRNAs. RNA Biol. 2015;12:92–100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615756</ArticleId><ArticleId IdType="pubmed">25826416</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu B., Wang C., Bie Y., Kong J., Wang A., Jin L., Qiu Y., Zhou X. Enoxacin shows broad-spectrum antiviral activity against diverse viruses by enhancing antiviral RNA interference in insects. J. Virol. 2022;96</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865501</ArticleId><ArticleId IdType="pubmed">34908449</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino N.D., Pinilla-Redondo R., Csörgő B., Bondy-Denomy J. Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies. Nat. Methods. 2020;17:471–479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8510557</ArticleId><ArticleId IdType="pubmed">32203383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelossof R., Fairchild L., Huang C.H., Widmer C., Sreedharan V.T., Sinha N., Lai D.Y., Guan Y., Premsrirut P.K., Tschaharganeh D.F., Hoffmann T., Thapar V., Xiang Q., Garippa R.J., Rätsch G., Zuber J., Lowe S.W., Leslie C.S., Fellmann C. Prediction of potent shRNAs with a sequential classification algorithm. Nat. Biotechnol. 2017;35:350–353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5416823</ArticleId><ArticleId IdType="pubmed">28263295</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 2004;22:326–330.</Citation><ArticleIdList><ArticleId IdType="pubmed">14758366</ArticleId></ArticleIdList></Reference><Reference><Citation>Schierhorn K.L., Sanchez-David R.Y., Maillard P.V. Mammalian antiviral RNAi is on the move. EMBO J. 2022;41</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9156964</ArticleId><ArticleId IdType="pubmed">35471636</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabalina S.A., Spiridonov A.N., Ogurtsov A.Y. Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinformatics. 2006;7:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1431570</ArticleId><ArticleId IdType="pubmed">16472402</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang R., Zhang F., Xu B., Xi H., Zhang X., Wang W., Wu L. Ribozyme-enhanced single-stranded AGO2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects. Nat. Commun. 2015;6:8430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4633630</ArticleId><ArticleId IdType="pubmed">26455506</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski D.M., De Serres G. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 2021;384:1576–1577.</Citation><ArticleIdList><ArticleId IdType="pubmed">33596348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer C., Gerlich D.W. Machine learning in cell biology - teaching computers to recognize phenotypes. J. Cell Sci. 2013;126:5529–5539.</Citation><ArticleIdList><ArticleId IdType="pubmed">24259662</ArticleId></ArticleIdList></Reference><Reference><Citation>Vert J.P., Foveau N., Lajaunie C., Vandenbrouck Y. An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics. 2006;7:520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1698581</ArticleId><ArticleId IdType="pubmed">17137497</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Li X., Ning W., Gong S., Yang F., Fang C., Gong Y., Wu D., Huang M., Gou Y., Fu S., Ren Y., Yang R., Qiu Y., Xue Y., Xu Y., Zhou X. Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19. Theranostics. 2021;11:8008–8026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315065</ArticleId><ArticleId IdType="pubmed">34335977</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittrup A., Lieberman J. Knocking down disease: a progress report on siRNA therapeutics. Nat. Rev. Genet. 2015;16:543–552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756474</ArticleId><ArticleId IdType="pubmed">26281785</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Belasco J.G. Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol. Cell. 2008;29:1–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18206964</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Yin W., Zhang Y., Shang W., Wang Z., Luan X., Tian G., Aisa H.A., Xu Y., Xiao G., Li J., Jiang H., Zhang S., Zhang L., Xu H.E., Shen J. Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2. Cell Res. 2021;31:1212–1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8477624</ArticleId><ArticleId IdType="pubmed">34584244</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.S., Maurin T., Robine N., Rasmussen K.D., Jeffrey K.L., Chandwani R., Papapetrou E.P., Sadelain M., O’Carroll D., Lai E.C. Conserved vertebrate miR-451 provides a platform for dicer-independent, AGO2-mediated microRNA biogenesis. Proc. Natl. Acad. Sci. U. S. A. 2010;107:15163–15168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2930549</ArticleId><ArticleId IdType="pubmed">20699384</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoda M., Cifuentes D., Izumi N., Sakaguchi Y., Suzuki T., Giraldez A.J., Tomari Y. Poly(a)-specific ribonuclease mediates 3’-end trimming of argonaute2-cleaved precursor microRNAs. Cell Rep. 2013;5:715–726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3856240</ArticleId><ArticleId IdType="pubmed">24209750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Liu Q., Sun Y., Li J., Liu J., Pan R., Cao L., Chen X., Li Y., Zhang Y., Xu K., Guo D., Zhou L., Lan K., Chen Y. Live attenuated coronavirus vaccines deficient in n7-methyltransferase activity induce both humoral and cellular immune responses in mice. Emerg. Microbes Infect. 2021;10:1626–1637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381960</ArticleId><ArticleId IdType="pubmed">34365904</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>